Prof. Anita Kamra Verma

Professor Anita Kamra Verma is working as Group Leader of Nanobiotech Lab, at Kirori Mal College, University of Delhi since 2003. Prof Verma a highly experienced nanobiotechnologist whose work is focused on cancer nanotherapeutics. Her research interests include developing in vivo models for quantifying nanoparticulate drug delivery for cancer, arthritis, wound healing and diabetes, and...
Read More
Dr. Rathi obtained Ph.D. degree in Chemistry from University of Delhi and currently working as Assistant Professor of Chemistry at Hansraj College University of Delhi, India. He was awarded Young Scientist Fellowship, Early Career Research Award from SERB-DST, Government of India; CAPES-Print Fellowship from Ministry of Education Brazil; and Excellence Award for In Service Teachers...
Read More
Dr. Poonam is a Fellow at the Delhi School of Public Health, Institution of Eminence (IoE), University of Delhi. She is leading an independent research group of doctoral students and postgraduate and graduate students in her research laboratory. Research-based on public health is extremely important and provides an excellent platform to collaborate with world- class...
Read More
Professor Dr Seema Mehra Parihar is presently a Fellow at Delhi School of Public Health (DSPH) , Institute of Eminence (IoE), University of Delhi and a Faculty at the Department of Geography at Kirori Mal College, University of Delhi, India. She is a teacher, researcher, and trainer of the trainers, speaker and author- a versatile...
Read More
Being a citizen of the Low Middle Income Country (LMIC) and a Public Health professional, I am working with the objective of minimizing the risk of death with the practice of affordable & deliverable disease management strategies for improving quality of life and reducing human suffering. I learned from my previous exposures and pieces of...
Read More
The significant issues with the currently available medications are drug toxicity and drug resistance. My main area of study interest is finding inhibitors/agonists that are target-specific, have low toxicity, and have strong effects. My laboratory’s research focuses on cancer (breast cancer and neuroblastoma) and rare genetic disorders (Fibrodysplasia Ossificans Progressiva). We use both in silico...
Read More